Evidence map›Paper›PMID 35313909›Full record

ArticleOrphanet journal of rare diseases2022

Development of a patient journey map for people living with cervical dystonia.

Monika Benson, Alberto Albanese, Kailash P Bhatia, Pascale Cavillon, Lorraine Cuffe, Kathrin König, Carola Reinhard, Holm Graessner

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Genetic Update and Treatment for Dystonia.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Monika BensonDystonia Europe, Brussels, Belgium.
Alberto AlbaneseEuropean Reference Network for Rare Neurological Diseases, Tübingen, Germany.
Kailash P BhatiaDepartment of Clinical and Movement Neuroscience, Institute of Neurology UCL, London, WC1N 3BG, UK.
Pascale CavillonPatient Centricity, Ipsen, Boulogne Billancourt, France.
Lorraine CuffeMedical Affairs, Ipsen, Slough, UK.
Kathrin KönigPARTNERSEITZ GmbH, Ludwigshafen, Germany.
Carola ReinhardEuropean Reference Network for Rare Neurological Diseases, Tübingen, Germany.
Holm GraessnerEuropean Reference Network for Rare Neurological Diseases, Tübingen, Germany. Holm.Graessner@med.uni-tuebingen.de.ORCID 0000-0001-9803-7183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient journey maps are increasingly used as a tool that enables healthcare providers to refine their service provision to best meet patient needs. We developed a cervical dystonia patient journey map (CDPJM) that describes the holistic patient experience from pre-diagnosis through to long-term treatment.

methodsThe CDPJM was developed in 2 stages; a patient survey (open questions and multichoice) of 15 patients with CD was conducted to inform the design of the CDPJM, which was then refined and validated by an expert-patient focus group.

resultsQualitative analysis of the patient survey supported five key stages of the patient journey: symptom onset, diagnosis and therapeutic relationship with healthcare professionals, initiation of care for CD, start of CD treatment, and living with treated CD. Following symptom onset, survey respondents described having multiple visits to their family doctor who prescribed strong pain killers and muscle relaxants and referred their patient to up to 10 different specialists for diagnosis. Over half (53.3%) of respondents had received ≥ 1 misdiagnosis. Respondents reported relief at having a diagnosis but a lack of understanding of the prognosis and treatment options; 46.7% said their neurologist did not spend enough time addressing their concerns. Survey respondents reported using a variety of alternative sources of information, including the internet (86.7%), self-help groups (66.7%) and information leaflets provided by health care professionals (60.0%). While botulinum toxin (BoNT) was consistently discussed as the main treatment option, some neurologists also mentioned physiotherapy, counselling, and other complementary approaches. However, patients were often left to seek complementary services themselves. Patients reported a 'rollercoaster' of relief with BoNT treatment with symptoms (and subsequent impact on daily life) returning towards the end of an injection cycle. "When BoNT works well I can return to an almost normal life … when the injections stop working so well, I have to rest more and avoid going to work and experience life restrictions."

conclusionsWe present the first patient journey map for CD that can be used to guide local service mapping and to compare current provision with what patients say they want and need.

Indexed as

TorticollisHumansPalliative CareSurveys and QuestionnairesAccess to treatmentCervical dystoniaPatient communicationPatient journeyPatient surveyRare disease

Identifiers

PMID35313909
PMCPMC8935780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.